Literature DB >> 25860648

Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection.

Nidhi Pandey1, Amita Jain, R K Garg, Rashmi Kumar, O P Agrawal, P V Lakshmana Rao.   

Abstract

Increased serum and mRNA levels of cytokines in patients with dengue virus (DV) infection suggest that cytokines are one of the key factors in the pathogenesis of disease caused by this virus. Here, we tested 211 serum and 56 mRNA samples from an equal number of dengue cases to determine the levels of interleukin-8 (IL-8), interferon gamma (IFN-γ), interleukin-10 (IL-10) and transforming growth factor beta (TGF-β). A total 70 serum and 15 mRNA samples from healthy individual were also tested for cytokines and served as controls. Serum and mRNA levels of IL-8 were highest in the earlier days of dengue infection. IFNγ levels peaked one or two days before defervescence. Levels of IL-10 and TGF-β were highest later in dengue infection, and TGF-β levels peaked on the day of defervescence. Mean levels of IFNγ, TGF β and IL-10 were higher in samples from dengue cases, irrespective of severity, than in healthy controls. In contrast, the level of IL-8 was significantly higher in samples from severe dengue cases and lower in cases of dengue without warning signs than in healthy controls. Children (82.2 % of 101 paediatric cases) commonly had severe dengue illness. Samples that were positive for anti-DV IgG antibody had higher levels of IL-8 and TGF β. DV-2 infections were associated with severe dengue illness. IL-8 and IFNγ levels were higher in the presence of warning signs of severe dengue. Levels of IL-8, IL-10 and TGF β were independently associated with disease outcome. These data provide evidence of an association of IL-8, IFNγ, TGF β and IL-10 levels with the severity of dengue illness. Especially, IL-8 levels can be used as a predictor of severe DV infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25860648     DOI: 10.1007/s00705-015-2410-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

Review 1.  Vaccines licensed and in clinical trials for the prevention of dengue.

Authors:  J Torresi; G Ebert; M Pellegrini
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

2.  Zika viral dynamics and shedding in rhesus and cynomolgus macaques.

Authors:  Christa E Osuna; So-Yon Lim; Claire Deleage; Bryan D Griffin; Derek Stein; Lukas T Schroeder; Robert Were Omange; Katharine Best; Ma Luo; Peter T Hraber; Hanne Andersen-Elyard; Erwing Fabian Cardozo Ojeda; Scott Huang; Dana L Vanlandingham; Stephen Higgs; Alan S Perelson; Jacob D Estes; David Safronetz; Mark G Lewis; James B Whitney
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

3.  Early Transcriptional Responses After Dengue Vaccination Mirror the Response to Natural Infection and Predict Neutralizing Antibody Titers.

Authors:  Stephen J Popper; Fiona R Strouts; Janet C Lindow; Henry K Cheng; Magelda Montoya; Angel Balmaseda; Anna P Durbin; Stephen S Whitehead; Eva Harris; Beth D Kirkpatrick; David A Relman
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

4.  IL-28 and IL-29 as protective markers in subject with dengue fever.

Authors:  Chih-Hsing Hung; Chung-Hao Huang; Lin Wang; Chun-Chi Huang; Meng-Chieh Wu; Yi-Ying Chin; Chun-Yu Lin; Ko Chang; Deng-Chyang Wu; Yen-Hsu Chen
Journal:  Med Microbiol Immunol       Date:  2017-02-25       Impact factor: 4.148

5.  Slow resolution of inflammation in severe adult dengue patients.

Authors:  Lingzhai Zhao; Xiuyan Huang; Wenxin Hong; Shuang Qiu; Jian Wang; Lei Yu; Yaoying Zeng; Xinghua Tan; Fuchun Zhang
Journal:  BMC Infect Dis       Date:  2016-06-14       Impact factor: 3.090

6.  Meta-analysis of biomarkers for severe dengue infections.

Authors:  Kuan-Meng Soo; Bahariah Khalid; Siew-Mooi Ching; Chau Ling Tham; Rusliza Basir; Hui-Yee Chee
Journal:  PeerJ       Date:  2017-09-15       Impact factor: 2.984

Review 7.  Roles of Interferons in Pregnant Women with Dengue Infection: Protective or Dangerous Factors.

Authors:  Hao Zhang; Zhiyi He; Wenting Zeng; Hong-Juan Peng
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-09-07       Impact factor: 2.471

8.  Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro.

Authors:  Francielle Tramontini Gomes de Sousa Cardozo; Gyulnar Baimukanova; Marion Christine Lanteri; Sheila Marie Keating; Frederico Moraes Ferreira; John Heitman; Cláudio Sérgio Pannuti; Shibani Pati; Camila Malta Romano; Ester Cerdeira Sabino
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

9.  Primary dengue virus infections induce differential cytokine production in Mexican patients.

Authors:  Sergio Isaac de la Cruz Hernández; Henry Nelson Puerta-Guardo; Hilario Flores Aguilar; Silvia González Mateos; Irma López Martinez; Vianney Ortiz-Navarrete; Juan E Ludert; Rosa María del Angel
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03       Impact factor: 2.743

10.  Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase.

Authors:  Dennis Tappe; José Vicente Pérez-Girón; Lorenzo Zammarchi; Jürgen Rissland; Davis F Ferreira; Thomas Jaenisch; Sergio Gómez-Medina; Stephan Günther; Alessandro Bartoloni; César Muñoz-Fontela; Jonas Schmidt-Chanasit
Journal:  Med Microbiol Immunol       Date:  2015-12-24       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.